These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21829028)

  • 1. Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
    Klimkowicz-Mrowiec A; Marona M; Spisak K; Jagiella J; Wolkow P; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 32(1):26-31. PubMed ID: 21829028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population.
    Klimkowicz-Mrowiec A; Marona M; Wolkow P; Witkowski A; Maruszak A; Styczynska M; Barcikowska M; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 31(6):417-23. PubMed ID: 21757906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese].
    Shi JJ; Zhang SZ; Ma C; Tang MN; Liu XH; Wang YC; Han HY; Guo YB; Feng RM; Miao GD
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):371-4. PubMed ID: 15090300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
    Leduc V; Poirier J
    Neurodegener Dis; 2008; 5(3-4):225-7. PubMed ID: 18322397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology.
    Leduc V; Théroux L; Dea D; Robitaille Y; Poirier J
    Eur J Neurosci; 2009 Nov; 30(9):1823-30. PubMed ID: 19863653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene.
    Pola R; Flex A; Ciaburri M; Rovella E; Valiani A; Reali G; Silveri MC; Bernabei R
    Neurosci Lett; 2005 Jul; 382(3):338-41. PubMed ID: 15925115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
    Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R
    Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Chin Med J (Engl); 2006 Jul; 119(14):1204-9. PubMed ID: 16863614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.
    Klugman A; Naughton DP; Isaac M; Shah I; Petroczi A; Tabet N
    J Alzheimers Dis; 2012; 30(3):467-74. PubMed ID: 22451323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests.
    Borkowska A; Ziolkowska-Kochan M; Rybakowski JK
    Hum Psychopharmacol; 2005 Aug; 20(6):409-14. PubMed ID: 15991260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease.
    Seripa D; Bizzarro A; Pilotto A; D'onofrio G; Vecchione G; Gallo AP; Cascavilla L; Paris F; Grandone E; Mecocci P; Santini SA; Masullo C; Pilotto A
    Pharmacogenet Genomics; 2011 Apr; 21(4):225-30. PubMed ID: 20859244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraoxonase 1 gene Gln192Arg polymorphism in and Alzheimer disease].
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):270-3. PubMed ID: 16780669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.
    Sato N; Ueki A; Ueno H; Shinjo H; Morita Y
    J Alzheimers Dis; 2009; 17(2):441-8. PubMed ID: 19363270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.
    Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.